Home US FDA Approval

US FDA Approval

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

Shanghai, July 23, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) in Shanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two inspections from the U.S....

Dr. Reddy’s announces the launch of over-the-counter, store-brand equivalent of Allegra-D® 12 HR...

Hyderabad, July 22, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced the launch of Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release...

Wockhardt Receives US FDA Approval for cancer drug

Mumbai, April 24, 2019: Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 50mg injection of Decitabine, which is used to treat certain forms of cancer. Wockhardt's Decitabine...

Lupin’s Pithampur Unit-3 (Indore) receives EIR from USFDA

Mumbai, April 18, 2019: Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) for its Pithampur (Unit-3) facility. The inspection was conducted between October 8, 2018 to October 18, 2018. Lupin’s Pithampur Unit-3 is involved...

India pharmaceuticals market expected to reach USD 73.5 billion by 2023

Mumbai, April 08, 2019: Market Research Future (MRFR) in its latest analysis titled, “Withering USFDA inspections: The Quality Challenge for Indian Drugmakers”the India pharmaceuticals market is growing at a significant rate and was worth approximately USD 45.5 billion in 2018 and...